Company news
Exagen Inc. news in 2023
Exagen Inc.'s news releases, calls and decks from 2023, newest first.
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 12, 2023
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
November 8, 2023
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 1, 2023
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 29, 2023
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 27, 2023
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 11, 2023
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 6, 2023
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 25, 2023
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
Exagen Inc. Appoints Paul Kim to Board of Directors
July 23, 2023
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 29, 2023
Exagen Inc. Reports First Quarter 2023 Results
May 14, 2023
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
April 23, 2023
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 19, 2023
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 5, 2023
Exagen Inc. to Participate in Upcoming March Conferences
February 26, 2023
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 29, 2023
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 22, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (January 2023)
Investor deck · 18 slides · Jan 9, 2023